Cardiovascular Disease in the Rheumatic Diseases: How Systemic Inflammation May Contribute to Atherogenesis
Cardiovascular disease remains the leading cause of mortality in the United States. The increased prevalence of atherosclerotic cardiovascular disease is well established in rheumatoid arthritis and systemic lupus erythematosus. Recently, studies of other rheumatic diseases, such as the systemic vasculidities, have also demonstrated accelerated atherosclerotic disease. The detection and delineation of the inflammatory pathways that contribute to atherogenesis in the general population are important in deriving insight into how disease-associated factors may initiate and participate in accelerated atherogenesis in patients with rheumatic diseases.
Keywords: Atherosclerosis; cardiovascular disease; inflammation; rheumatic diseases
Document Type: Research Article
Affiliations: University of Pittsburgh,Division of Rheumatology and Clinical Immunology, 3500 Terrace St. BST S718, Pittsburgh, PA 15213, USA.
Publication date: 01 August 2006
- Current Rheumatology Reviews publishes frontier reviews on all the latest advances on rheumatology and its related areas e.g. pharmacology, pathogenesis, epidemiology, clinical care, and therapy. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field.
The journal is essential reading for all researchers and clinicians in rheumatology. - Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content